fangchinoline has been researched along with Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JL; Gao, X; He, GY; Huang, JG; Li, Y; Wang, CD; Wang, YS; Yan, X; Yang, GX; Zhou, SY; Zou, A | 1 |
1 other study(ies) available for fangchinoline and Carcinoma
Article | Year |
---|---|
Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzylisoquinolines; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D; Cyclin-Dependent Kinase Inhibitor p27; G2 Phase; Humans; Male; Mice; Mice, Nude; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; S Phase; Xenograft Model Antitumor Assays | 2010 |